Acob, Abdilla C.
HRN: 27-08-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/20/2025
05/27/2025
IV
4.5
Q6
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes